265 related articles for article (PubMed ID: 22780881)
1. Critical effect of peptide cyclization on the potency of peptide inhibitors against Dengue virus NS2B-NS3 protease.
Xu S; Li H; Shao X; Fan C; Ericksen B; Liu J; Chi C; Wang C
J Med Chem; 2012 Aug; 55(15):6881-7. PubMed ID: 22780881
[TBL] [Abstract][Full Text] [Related]
2. Design and docking studies of peptide inhibitors as potential antiviral drugs for dengue virus ns2b/ns3 protease.
Velmurugan D; Mythily U; Rao K
Protein Pept Lett; 2014; 21(8):815-27. PubMed ID: 23855663
[TBL] [Abstract][Full Text] [Related]
3. Discovery of novel cyclic peptide inhibitors of dengue virus NS2B-NS3 protease with antiviral activity.
Takagi Y; Matsui K; Nobori H; Maeda H; Sato A; Kurosu T; Orba Y; Sawa H; Hattori K; Higashino K; Numata Y; Yoshida Y
Bioorg Med Chem Lett; 2017 Aug; 27(15):3586-3590. PubMed ID: 28539222
[TBL] [Abstract][Full Text] [Related]
4. Dengue Virus NS2B/NS3 Protease Inhibitors Exploiting the Prime Side.
Lin KH; Ali A; Rusere L; Soumana DI; Kurt Yilmaz N; Schiffer CA
J Virol; 2017 May; 91(10):. PubMed ID: 28298600
[TBL] [Abstract][Full Text] [Related]
5. Flavonoids as noncompetitive inhibitors of Dengue virus NS2B-NS3 protease: inhibition kinetics and docking studies.
de Sousa LR; Wu H; Nebo L; Fernandes JB; da Silva MF; Kiefer W; Kanitz M; Bodem J; Diederich WE; Schirmeister T; Vieira PC
Bioorg Med Chem; 2015 Feb; 23(3):466-70. PubMed ID: 25564380
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and disulfide bond connectivity-activity studies of a kalata B1-inspired cyclopeptide against dengue NS2B-NS3 protease.
Gao Y; Cui T; Lam Y
Bioorg Med Chem; 2010 Feb; 18(3):1331-6. PubMed ID: 20042339
[TBL] [Abstract][Full Text] [Related]
7. Novel potent hepatitis C virus NS3 serine protease inhibitors derived from proline-based macrocycles.
Chen KX; Njoroge FG; Arasappan A; Venkatraman S; Vibulbhan B; Yang W; Parekh TN; Pichardo J; Prongay A; Cheng KC; Butkiewicz N; Yao N; Madison V; Girijavallabhan V
J Med Chem; 2006 Feb; 49(3):995-1005. PubMed ID: 16451065
[TBL] [Abstract][Full Text] [Related]
8. Effects of NS2B-NS3 protease and furin inhibition on West Nile and Dengue virus replication.
Kouretova J; Hammamy MZ; Epp A; Hardes K; Kallis S; Zhang L; Hilgenfeld R; Bartenschlager R; Steinmetzer T
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):712-721. PubMed ID: 28385094
[TBL] [Abstract][Full Text] [Related]
9. Discovery of novel small molecule inhibitors of dengue viral NS2B-NS3 protease using virtual screening and scaffold hopping.
Deng J; Li N; Liu H; Zuo Z; Liew OW; Xu W; Chen G; Tong X; Tang W; Zhu J; Zuo J; Jiang H; Yang CG; Li J; Zhu W
J Med Chem; 2012 Jul; 55(14):6278-93. PubMed ID: 22742496
[TBL] [Abstract][Full Text] [Related]
10. In silico evaluation of inhibitory potential of triterpenoids from Azadirachta indica against therapeutic target of dengue virus, NS2B-NS3 protease.
Dwivedi VD; Tripathi IP; Mishra SK
J Vector Borne Dis; 2016; 53(2):156-61. PubMed ID: 27353586
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the West Nile virus protease substrate specificity and inhibitors.
Mueller NH; Yon C; Ganesh VK; Padmanabhan R
Int J Biochem Cell Biol; 2007; 39(3):606-14. PubMed ID: 17188926
[TBL] [Abstract][Full Text] [Related]
12. Discovery and SAR studies of methionine-proline anilides as dengue virus NS2B-NS3 protease inhibitors.
Zhou GC; Weng Z; Shao X; Liu F; Nie X; Liu J; Wang D; Wang C; Guo K
Bioorg Med Chem Lett; 2013 Dec; 23(24):6549-54. PubMed ID: 24268549
[TBL] [Abstract][Full Text] [Related]
13. In-silico identification and evaluation of plant flavonoids as dengue NS2B/NS3 protease inhibitors using molecular docking and simulation approach.
Qamar MT; Ashfaq UA; Tusleem K; Mumtaz A; Tariq Q; Goheer A; Ahmed B
Pak J Pharm Sci; 2017 Nov; 30(6):2119-2137. PubMed ID: 29175781
[TBL] [Abstract][Full Text] [Related]
14. Identification of fused bicyclic derivatives of pyrrolidine and imidazolidinone as dengue virus-2 NS2B-NS3 protease inhibitors.
Weng Z; Shao X; Graf D; Wang C; Klein CD; Wang J; Zhou GC
Eur J Med Chem; 2017 Jan; 125():751-759. PubMed ID: 27721158
[TBL] [Abstract][Full Text] [Related]
15. Antiviral activities of 15 dengue NS2B-NS3 protease inhibitors using a human cell-based viral quantification assay.
Chu JJ; Lee RC; Ang MJ; Wang WL; Lim HA; Wee JL; Joy J; Hill J; Brian Chia CS
Antiviral Res; 2015 Jun; 118():68-74. PubMed ID: 25823617
[TBL] [Abstract][Full Text] [Related]
16. Highly potent and selective peptide-based inhibitors of the hepatitis C virus serine protease: towards smaller inhibitors.
Llinàs-Brunet M; Bailey M; Fazal G; Ghiro E; Gorys V; Goulet S; Halmos T; Maurice R; Poirier M; Poupart MA; Rancourt J; Thibeault D; Wernic D; Lamarre D
Bioorg Med Chem Lett; 2000 Oct; 10(20):2267-70. PubMed ID: 11055335
[TBL] [Abstract][Full Text] [Related]
17. Retro peptide-hybrids as selective inhibitors of the Dengue virus NS2B-NS3 protease.
Nitsche C; Behnam MA; Steuer C; Klein CD
Antiviral Res; 2012 Apr; 94(1):72-9. PubMed ID: 22391061
[TBL] [Abstract][Full Text] [Related]
18. Structure-guided Discovery of a Novel Non-peptide Inhibitor of Dengue Virus NS2B-NS3 Protease.
Li L; Basavannacharya C; Chan KW; Shang L; Vasudevan SG; Yin Z
Chem Biol Drug Des; 2015 Sep; 86(3):255-64. PubMed ID: 25533891
[TBL] [Abstract][Full Text] [Related]
19. Peptide-β-lactam Inhibitors of Dengue and West Nile Virus NS2B-NS3 Protease Display Two Distinct Binding Modes.
Dražić T; Kopf S; Corridan J; Leuthold MM; Bertoša B; Klein CD
J Med Chem; 2020 Jan; 63(1):140-156. PubMed ID: 31804823
[TBL] [Abstract][Full Text] [Related]
20. Thiazolidinone-peptide hybrids as dengue virus protease inhibitors with antiviral activity in cell culture.
Nitsche C; Schreier VN; Behnam MA; Kumar A; Bartenschlager R; Klein CD
J Med Chem; 2013 Nov; 56(21):8389-403. PubMed ID: 24083834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]